President Donald Trump signed an executive order aimed at removing barriers to psychedelic drugs as potential treatments for serious mental illness on Saturday, April 18, 2026.
The announcement is driving a sharp premarket rally in shares of several clinical-stage companies developing psychedelic- and neuroactive compound-based therapies.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.